Italian multinational laboratory diagnostics firm DiaSorin is to acquire Luminex Corporation for a price of US$37 per share in an all-cash transaction, which values Luminex at approximately US$1.8bn. The cash…
Italian multinational laboratory diagnostics firm DiaSorin is to acquire Luminex Corporation for a price of US$37 per share in an all-cash transaction, which values Luminex at approximately US$1.8bn. The cash…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


